Han et al. performed a case-control study by using a series of inflammation markers (e.g. IL-6, IL-10, and TNF-α) among 102 COVID-19 patients and finally highlighted the significance of IL-6 and IL-10 as illness severity predictors [32]. This evidence concerns the gene IL6 and COVID-19.